首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma (Cancer DOI: 10.1002/cncr.28521)
【24h】

Erratum: Loss of BAP1 protein expression is an independent marker of poor prognosis in patients with low-risk clear cell renal cell carcinoma (Cancer DOI: 10.1002/cncr.28521)

机译:勘误:BAP1蛋白表达的丧失是低危透明细胞肾细胞癌患者预后不良的独立标志(癌症DOI:10.1002 / cncr.28521)

获取原文
获取原文并翻译 | 示例
           

摘要

The authors regret that they identified several errors in the manuscript after they approved the final proofs. The corrections are underlined or commented on below. In the MATERIALS AND METHODS section, first paragraph under Patient Selection, fourth line should read "between 1990 and 2009." In the MATERIALS AND METHODS section, first paragraph under Statistical Methods, the following text should be deleted, "adjusting for the competing risk of death due to other causes." In the RESULTS section, first paragraph under Association of BAP 1 With Clinical and Pathologic Characteristics, a sentence should be revised to read "A total of 1092 patients who did not die from RCC (and were thus censored) had a mean of 8.3 years of follow up (median, 7.7 years; range, 0.003-22.1 years)."
机译:作者感到遗憾的是,他们在批准最终证明后发现了稿件中的几个错误。更正在下面带有下划线或评论。在“材料和方法”部分的“患者选择”下的第一段,第四行应为“ 1990年至2009年之间”。在“材料和方法”部分的“统计方法”下的第一段中,应删除以下文字,“调整其他原因引起的死亡竞争风险”。在“结果”部分中,与临床和病理特征相关的BAP 1关联下的第一段,句子应改为:“共有1092名未因RCC死亡(因此接受检查)的患者平均有8.3年的病史。随访(中位,7.7年;范围,0.003-22.1年)。”

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号